Baidu Ventures and AliHealth both invested in a series C round for the genome sequencing technology provider, which counts BGI as an existing investor.
China-based genome sequencing platform developer Geneplus Technology has picked up RMB750m ($116m) in a series C round featuring internet group Baidu and e-commerce group Alibaba, DealStreetAsia reported yesterday.
Financial services firm China Construction Bank’s CCB International unit led the round, which included fellow China Construction Bank subsidiary CCB Capital and Jinmao Capital, an investment arm of state-owned real estate developer China Jinmao Holding, as well as GGV Capital and Fortunate Capital.
Alibaba was represented in the round by its healthcare…
